| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.9B | $16.5B | $13.9B | $8.8B | $1.5B | $0.0B | $2.5B | $2.3B |
| Cost of Revenue | $9.1B | $8.7B | $7.8B | $6.6B | $2.7B | $2.8B | $6.1B | $5.3B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.2B | $2.1B | $1.8B | $1.6B | $1.4B | $1.2B | $1.6B | $1.3B |
| Operating Income | $4.9B | $4.1B | $2.9B | $-0.8B | $-3.9B | $-1.0B | $0.3B | $0.4B |
| Net Income | $4.3B | $2.9B | $1.7B | $-2.2B | $-5.3B | $-1.4B | $0.3B | $0.3B |
| EPS (Basic) | $15.75 | $11.00 | $6.63 | $-8.45 | $-20.89 | $-6.09 | $1.31 | $1.51 |
| EPS (Diluted) | $15.61 | $10.94 | $6.31 | $-8.45 | $-20.89 | $-6.09 | $1.30 | $1.50 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $41.6B | $37.1B | $35.1B | $33.8B | $32.3B | $32.5B | $30.3B | $27.7B |
| Current Assets | $2.2B | $1.7B | $1.8B | $3.2B | $3.6B | $4.3B | $1.2B | $1.2B |
| Cash & Equivalents | $0.8B | $0.4B | $0.5B | $1.9B | $2.7B | $3.7B | $0.2B | $0.3B |
| Total Liabilities | $31.4B | $29.3B | $30.2B | $30.9B | $27.2B | $23.7B | $17.6B | $16.1B |
| Current Liabilities | $12.1B | $9.8B | $9.4B | $8.6B | $7.3B | $4.5B | $8.0B | $7.1B |
| Stockholders' Equity | $10.0B | $7.6B | $4.7B | $2.9B | $5.1B | $8.8B | $12.2B | $11.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6.5B | $5.3B | $4.5B | $0.5B | $-1.9B | $-3.7B | $3.7B | $3.5B |
| Investing Cash Flow | $-5.0B | $-3.4B | $-3.9B | $-3.0B | $-2.1B | $-2.2B | $-3.1B | $-4.5B |
| Capital Expenditures | $5.2B | $3.3B | $3.9B | $2.7B | $2.2B | $2.0B | $3.0B | $3.7B |
| Financing Cash Flow | $-1.0B | $-1.9B | $-2.0B | $1.7B | $3.0B | $9.3B | $-0.7B | $1.2B |